CCN2 and Nephropathy: Many preclinical studies targeting CCN2, by neutralizing antibodies, antisense oligonucleotides, gene silencing, or studies in knockout mice, have proposed CCN2 as a therapeutic target in experimental kidney damage [24,25,26].